Similar articles

• Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis.

  Wu W, Yao DF, Qiu LW, Sai WL, Shen JJ, Yu HB, Wu XH, Li YM, Wang YL, Gu WJ. Wu W, et al. Hepatobiliary Pancreat Dis Int. 2009 Oct;8(5):504-9. Hepatobiliary Pancreat Dis Int. 2009. PMID: 19822494
• [Effect of siRNA-mediated inhibition of nuclear transcription factor-kappa B on apoptosis of hepatocarcinoma cells].

  Wang YL, Yao DF, Wu W, Sai WL, Qiu LW, Yang JL, Zhu JW. Wang YL, et al. Zhonghua Gan Zang Bing Za Zhi. 2010 Aug;18(8):609-13. doi: 10.3760/cma.j.issn.1007-3418.2010.08.014. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 20825717 Chinese.
• Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice.

  Yau TO, Chan CF, Gee-San Lam S, Cheung OF, Ching YP, Jin DY, Sham MH, Ng IO. Yau TO, et al. J Pathol. 2009 Feb;217(3):353-61. doi: 10.1002/path.2451. J Pathol. 2009. PMID: 19090486
• The role of somatostatin analogs in the management of hepatocellular carcinoma.

  D'Agostino L, Manguso F, Pivonello R, Colao A. D'Agostino L, et al. J Endocrinol Invest. 2003;26(8 Suppl):131-3. J Endocrinol Invest. 2003. PMID: 15233229 Review. No abstract available.
• Role of NF-κB in hepatocarcinogenesis and its potential inhibition by dietary antioxidants.

  Glauert HP. Glauert HP. Curr Cancer Drug Targets. 2012 Nov 1;12(9):1160-72. doi: 10.2174/156800912803987931. Curr Cancer Drug Targets. 2012. PMID: 22873217 Review.